FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225313142> ?p ?o ?g. }

• W4225313142 endingPage "1519" @default.
• W4225313142 startingPage "1516" @default.
• W4225313142 abstract "Intracerebral hemorrhage (ICH) is the deadliest form of stroke. In observational studies, lower serum magnesium has been linked to more hematoma expansion (HE) and intracranial hemorrhage, implying that supplemental magnesium sulfate is a potential acute treatment for patients with ICH and could reduce HE. FAST-MAG (Field Administration of Stroke Therapy - Magnesium) was a clinical trial of magnesium sulfate started prehospital in patients with acute stroke within 2 hours of last known well enrolled. CT was not required prior to enrollment, and several hundred patients with acute ICH were enrolled. In this ancillary analysis, we assessed the effect of magnesium sulfate treatment upon HE in patients with acute ICH.We retrospectively analyzed data that were prospectively collected in the FAST-MAG study. Patients received intravenous magnesium sulfate or matched placebo within 2 hours of onset. We compared HE among patients allocated to intravenous magnesium sulfate or placebo with a Mann-Whitney U. We used the same method to compare neurological deficit severity (National Institutes of Health Stroke Scale) and global disability (modified Rankin Scale) at 3 months.Among 268 patients with ICH meeting study entry criteria, mean 65.4±13/4 years, 33% were female, and 211 (79%) had a history of hypertension. Initial deficit severities were median (interquartile range) of 4 (3-5) on the Los Angeles Motor Scale in the field and National Institutes of Health Stroke Scale score of 16 (9.5-25.5) early after hospital arrival. Follow-up brain imaging was performed a median of 17.1 (11.3-22.7) hours after first scan. The magnesium and placebo groups did not statistically differ in hematoma volume on arrival, 10.1 (5.6-28.7) versus 12.4 (5.6-28.7) mL (P=0.6), or HE, 2.0 (0.1-7.4) versus 1.5 (-0.2 to 8) mL (P=0.5). There was no difference in functional outcomes (modified Rankin Scale score of 3-6), 59% versus 50% (P=0.5).Magnesium sulfate did not reduce HE or improve functional outcomes at 90 days. A benefit for patients with initial hypomagnesemia was not addressed.URL: https://www.gov; Unique identifier: NCT00059332." @default.
• W4225313142 created "2022-05-05" @default.
• W4225313142 creator A5019276004 @default.
• W4225313142 creator A5022224139 @default.
• W4225313142 creator A5022823811 @default.
• W4225313142 creator A5028449685 @default.
• W4225313142 creator A5034914464 @default.
• W4225313142 creator A5057703354 @default.
• W4225313142 creator A5059027425 @default.
• W4225313142 creator A5059445912 @default.
• W4225313142 creator A5060704735 @default.
• W4225313142 creator A5066106442 @default.
• W4225313142 creator A5075359983 @default.
• W4225313142 date "2022-05-01" @default.
• W4225313142 modified "2023-10-13" @default.
• W4225313142 title "Magnesium Sulfate and Hematoma Expansion: An Ancillary Analysis of the FAST-MAG Randomized Trial" @default.
• W4225313142 cites W1995135251 @default.
• W4225313142 cites W2007301755 @default.
• W4225313142 cites W2094585602 @default.
• W4225313142 cites W2121451738 @default.
• W4225313142 cites W2142640478 @default.
• W4225313142 cites W2155070090 @default.
• W4225313142 cites W2158474808 @default.
• W4225313142 cites W2168109100 @default.
• W4225313142 cites W2736956052 @default.
• W4225313142 cites W2804714053 @default.
• W4225313142 cites W2988558243 @default.
• W4225313142 cites W3029589626 @default.
• W4225313142 cites W4238103798 @default.
• W4225313142 doi "https://doi.org/10.1161/strokeaha.121.037999" @default.
• W4225313142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35380053" @default.
• W4225313142 hasPublicationYear "2022" @default.
• W4225313142 type Work @default.
• W4225313142 citedByCount "2" @default.
• W4225313142 countsByYear W42253131422022 @default.
• W4225313142 crossrefType "journal-article" @default.
• W4225313142 hasAuthorship W4225313142A5019276004 @default.
• W4225313142 hasAuthorship W4225313142A5022224139 @default.
• W4225313142 hasAuthorship W4225313142A5022823811 @default.
• W4225313142 hasAuthorship W4225313142A5028449685 @default.
• W4225313142 hasAuthorship W4225313142A5034914464 @default.
• W4225313142 hasAuthorship W4225313142A5057703354 @default.
• W4225313142 hasAuthorship W4225313142A5059027425 @default.
• W4225313142 hasAuthorship W4225313142A5059445912 @default.
• W4225313142 hasAuthorship W4225313142A5060704735 @default.
• W4225313142 hasAuthorship W4225313142A5066106442 @default.
• W4225313142 hasAuthorship W4225313142A5075359983 @default.
• W4225313142 hasBestOaLocation W42253131421 @default.
• W4225313142 hasConcept C119060515 @default.
• W4225313142 hasConcept C126322002 @default.
• W4225313142 hasConcept C127413603 @default.
• W4225313142 hasConcept C141071460 @default.
• W4225313142 hasConcept C142724271 @default.
• W4225313142 hasConcept C168563851 @default.
• W4225313142 hasConcept C17624336 @default.
• W4225313142 hasConcept C191897082 @default.
• W4225313142 hasConcept C192562407 @default.
• W4225313142 hasConcept C204787440 @default.
• W4225313142 hasConcept C27081682 @default.
• W4225313142 hasConcept C2777094939 @default.
• W4225313142 hasConcept C2779662492 @default.
• W4225313142 hasConcept C2780645631 @default.
• W4225313142 hasConcept C2780931571 @default.
• W4225313142 hasConcept C3020199598 @default.
• W4225313142 hasConcept C42219234 @default.
• W4225313142 hasConcept C541997718 @default.
• W4225313142 hasConcept C543218039 @default.
• W4225313142 hasConcept C71924100 @default.
• W4225313142 hasConcept C78519656 @default.
• W4225313142 hasConceptScore W4225313142C119060515 @default.
• W4225313142 hasConceptScore W4225313142C126322002 @default.
• W4225313142 hasConceptScore W4225313142C127413603 @default.
• W4225313142 hasConceptScore W4225313142C141071460 @default.
• W4225313142 hasConceptScore W4225313142C142724271 @default.
• W4225313142 hasConceptScore W4225313142C168563851 @default.
• W4225313142 hasConceptScore W4225313142C17624336 @default.
• W4225313142 hasConceptScore W4225313142C191897082 @default.
• W4225313142 hasConceptScore W4225313142C192562407 @default.
• W4225313142 hasConceptScore W4225313142C204787440 @default.
• W4225313142 hasConceptScore W4225313142C27081682 @default.
• W4225313142 hasConceptScore W4225313142C2777094939 @default.
• W4225313142 hasConceptScore W4225313142C2779662492 @default.
• W4225313142 hasConceptScore W4225313142C2780645631 @default.
• W4225313142 hasConceptScore W4225313142C2780931571 @default.
• W4225313142 hasConceptScore W4225313142C3020199598 @default.
• W4225313142 hasConceptScore W4225313142C42219234 @default.
• W4225313142 hasConceptScore W4225313142C541997718 @default.
• W4225313142 hasConceptScore W4225313142C543218039 @default.
• W4225313142 hasConceptScore W4225313142C71924100 @default.
• W4225313142 hasConceptScore W4225313142C78519656 @default.
• W4225313142 hasIssue "5" @default.
• W4225313142 hasLocation W42253131421 @default.
• W4225313142 hasLocation W42253131422 @default.
• W4225313142 hasOpenAccess W4225313142 @default.
• W4225313142 hasPrimaryLocation W42253131421 @default.
• W4225313142 hasRelatedWork W2033732858 @default.
• W4225313142 hasRelatedWork W2897582587 @default.
• W4225313142 hasRelatedWork W2914947941 @default.

• next